Research Antibodies Market Growth Accelerated by Rising Use of Antibodies in Disease Diagnosis and Treatment


 Research antibodies find extensive use in various research applications such as disease diagnosis, drug development, and treatment. Some of the major products associated with this market are primary antibodies, secondary antibodies, and HRP-conjugated antibodies. Primary antibodies are used in techniques like immunohistochemistry, ELISA, flow cytometry, and western blotting to detect specific antigens in cells. Secondary antibodies then attach to the primary antibodies to make the detection and visualization of antigens simpler. HRP-conjugated antibodies catalyze the conversion of colorless chromogens into colored compounds, thereby serving as detection probes in assays. The global Research Antibodies Market is estimated to be valued at US$ 3,632 million in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2024.


Market key trends: The growing use of antibodies in disease diagnosis and treatment has been a major trend contributing to the market growth. Research antibodies play a pivotal role in the development of various diagnostic techniques and are extensively used in the identification of biomarkers for major diseases like cancer. They aid in the detection of antigens/biomarkers that indicate the presence/absence of diseases. This has significantly helped clinicians adopt antibody-based detection for the precise diagnosis and staging of various chronic and infectious conditions. Moreover, the development of novel antibody therapeutics for improved treatment outcomes has further stimulated the demand for research antibodies from pharmaceutical companies.

Segment Analysis
The global research antibodies market is dominated by catalog antibodies segment as they offer antibodies for commonly studied research areas such as cell signaling, epigenetics, and apoptosis at affordable prices. Within catalog antibodies, primary antibodies dominate due to their wide application in detecting target proteins and application specific monoclonal antibodies being developed by key players.

Key Takeaways
The global research antibodies market is expected to witness high growth.

Regional analysis: North America dominates the research antibodies market due to presence of majority of key players and availability of funding for research activities. Asia Pacific is fastest growing region due to increasing investments by government and private players in research facilities and advancements in healthcare infrastructure.

Key players operating in the research antibodies market are Thermo Fisher Scientific, Merck Group, Abbott, Bio-Rad Laboratories, F. Hoffman-La Roche Ltd., Agilent Technologies, Abcam PLC, Becton, Dickinson and Company, GenScript, and Cell Signaling Technology Inc. Thermo Fisher Scientific and Merck Group capture significant share in research antibodies market owing to their diverse product portfolio and strong distribution network across major markets. 

Comments

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure